$PHM
PULTEGROUP INC/MI/ Stock $phm

$phm Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000082241621000018 Filed on April 27, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$2.730B	$2.295B
YoY Change	18.95%	14.94%
Cost Of Revenue	$2.000B	$1.745B
YoY Change	14.62%	14.32%
Gross Profit	$729.8M	$550.2M
YoY Change	32.64%	16.96%
Gross Profit Margin	26.73%	23.97%
Selling, General & Admin	$271.7M	$263.7M
YoY Change	3.04%	4.33%
% of Gross Profit	37.23%	47.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$17.10M	$15.10M
YoY Change	13.25%	14.39%
% of Gross Profit	2.34%	2.74%
Operating Expenses	$271.7M	$263.7M
YoY Change	3.04%	4.33%
Operating Profit	$458.1M	$286.5M
YoY Change	59.88%	31.63%
Interest Expense	$1.300M	$3.600M
YoY Change	-63.89%	-25.0%
% of Operating Profit	0.28%	1.26%
Other Income/Expense, Net	-$2.639M	-$2.524M
YoY Change	4.56%	159.4%
Pretax Income	$394.1M	$263.8M
YoY Change	49.39%	21.72%
Income Tax	$89.95M	$60.06M
% Of Pretax Income	22.83%	22.77%
Net Earnings	$304.1M	$203.7M
YoY Change	49.28%	22.16%
Net Earnings / Revenue	11.14%	8.88%
Basic Earnings Per Share	$1.14	$0.75
Diluted Earnings Per Share	$1.13	$0.74
COMMON SHARES
Basic Shares Outstanding	265.4M shares	270.0M shares
Diluted Shares Outstanding	266.0M shares	271.2M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.580B	$1.817B
YoY Change	-13.04%	72.23%
Cash & Equivalents	$1.580B	$1.817B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$7.975B	$7.858B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$9.555B	$9.675B
YoY Change	-1.24%	13.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$69.00M	$76.00M
YoY Change	-9.21%	4.11%
Goodwill
YoY Change
Intangibles		$178.6M
YoY Change		44.29%
Long-Term Investments	$39.56M	$54.50M
YoY Change	-27.41%	-2.21%
Other Assets	$228.0M	$216.0M
YoY Change	5.56%	-31.65%
Total Long-Term Assets	$1.891B	$1.748B
YoY Change	8.14%	6.26%
TOTAL ASSETS
Total Short-Term Assets	$9.555B	$9.675B
Total Long-Term Assets	$1.891B	$1.748B
Total Assets	$11.45B	$11.42B
YoY Change	0.2%	11.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$405.0M	$430.0M
YoY Change	-5.81%	-3.15%
Accrued Expenses	$1.353B	$1.304B
YoY Change	3.76%	3.08%
Deferred Revenue
YoY Change
Short-Term Debt	$271.0M	$270.0M
YoY Change	0.37%	21.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.730B	$2.422B
YoY Change	12.72%	7.93%
LONG-TERM LIABILITIES
Long-Term Debt	$2.032B	$3.456B
YoY Change	-41.2%	14.29%
Other Long-Term Liabilities		$16.00M
YoY Change		220.0%
Total Long-Term Liabilities	$2.032B	$3.472B
YoY Change	-41.47%	14.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.730B	$2.422B
Total Long-Term Liabilities	$2.032B	$3.472B
Total Liabilities	$4.760B	$5.893B
YoY Change	-19.22%	11.74%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.685B	$5.530B
YoY Change
Total Liabilities & Shareholders Equity	$11.45B	$11.42B
YoY Change	0.2%	11.91%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$304.1M	$203.7M
YoY Change	49.28%	22.16%
Depreciation, Depletion And Amortization	$17.10M	$15.10M
YoY Change	13.25%	14.39%
Cash From Operating Activities	$176.7M	$204.6M
YoY Change	-13.62%	28.77%
INVESTING ACTIVITIES
Capital Expenditures	$14.75M	$20.14M
YoY Change	-26.75%	25.32%
Acquisitions	$10.40M	$83.20M
YoY Change	-87.5%
Other Investing Activities	-$698.0K	-$1.706M
YoY Change	-59.09%	486.25%
Cash From Investing Activities	-$27.62M	-$95.80M
YoY Change	-71.16%	461.26%
FINANCING ACTIVITIES
Cash Dividend Paid	$37.61M	$32.74M
YoY Change	14.88%	6.29%
Common Stock Issuance & Retirement, Net	$153.7M	$95.63M
YoY Change	60.72%	305.99%
Debt Paid & Issued, Net	$794.4M	$9.245M
YoY Change	8493.13%	156.45%
Cash From Financing Activities	-$1.137B	$491.0M
YoY Change	-331.64%	-352.32%
NET CHANGE
Cash From Operating Activities	$176.7M	$204.6M
Cash From Investing Activities	-$27.62M	-$95.80M
Cash From Financing Activities	-$1.137B	$491.0M
Net Change In Cash	-$988.2M	$599.8M
YoY Change	-264.75%	-1237.12%
FREE CASH FLOW
Cash From Operating Activities	$176.7M	$204.6M
Capital Expenditures	$14.75M	$20.14M
Free Cash Flow	$162.0M	$184.5M
YoY Change	-12.19%	29.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000822416
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	1-9804
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	PULTEGROUP, INC.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MI
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-2766606
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3350 Peachtree Road NE, Suite 150
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta,
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30326
CY2021Q1	dei	City Area Code CityAreaCode	404
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	978-6400
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	262966121	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1579586000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2582205000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	64468000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	50030000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1644054000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2632235000	USD
CY2021Q1	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	7975211000	USD
CY2020Q4	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	7721798000	USD
CY2021Q1	us-gaap	Inventory Real Estate Held For Sale InventoryRealEstateHeldForSale	31796000	USD
CY2020Q4	us-gaap	Inventory Real Estate Held For Sale InventoryRealEstateHeldForSale	27962000	USD
CY2021Q1	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	495049000	USD
CY2020Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	564979000	USD
CY2021Q1	us-gaap	Equity Method Investments EquityMethodInvestments	39558000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	35562000	USD
CY2021Q1	us-gaap	Other Assets OtherAssets	969437000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	923270000	USD
CY2021Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	158432000	USD
CY2020Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	163425000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	132204000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	136267000	USD
CY2021Q1	us-gaap	Assets Assets	11445741000	USD
CY2020Q4	us-gaap	Assets Assets	12205498000	USD
CY2021Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	404564000	USD
CY2020Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	511321000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	589634000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	449474000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	110884000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	103548000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1352629000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1407043000	USD
CY2021Q1	us-gaap	Line Of Credit LineOfCredit	270819000	USD
CY2020Q4	us-gaap	Line Of Credit LineOfCredit	411821000	USD
CY2021Q1	us-gaap	Notes Payable NotesPayable	2031937000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	2752302000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	4760467000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	5635509000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	6685274000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6569989000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11445741000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12205498000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	271686000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	263669000	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-61469000	USD
CY2020Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2639000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2524000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	394052000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	263769000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	89945000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60058000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	304107000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	203711000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.14
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.74
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.14
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.12
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	265407000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	270000000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	605000	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1218000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	266012000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	271218000	shares
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	304107000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	203711000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	25000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	25000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	25000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	25000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	304132000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	203736000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6569989000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4181000	USD
CY2021Q1	us-gaap	Dividends Dividends	37325000	USD
CY2021Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	153703000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	10566000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8555000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	304107000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	25000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	6685274000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	5458180000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	51000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4095000	USD
CY2020Q1	us-gaap	Dividends Dividends	32609000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	95676000	USD
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	14838000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8187000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	203711000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	25000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	5530391000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	304107000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	203711000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	11391000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	19955000	USD
CY2021Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	1368000	USD
CY2020Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	9729000	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-61469000	USD
CY2020Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	20190000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17142000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15149000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11630000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11479000	USD
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	687000	USD
CY2020Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	903000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	243947000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	189364000	USD
CY2021Q1	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	-69930000	USD
CY2020Q1	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	-145113000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	54303000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3534000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1352000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-26910000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	176748000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	204615000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14752000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20139000	USD
CY2021Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	8169000	USD
CY2020Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	663000	USD
CY2021Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5000000	USD
CY2020Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	6500000	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	10400000	USD
CY2020Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	83200000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-698000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1706000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27623000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-95796000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	794435000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	9245000	USD
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2020Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	700000000	USD
CY2021Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	-141002000	USD
CY2020Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	-56573000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	153703000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	95676000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10566000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	14838000	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	37611000	USD
CY2020Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	32740000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1137306000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	490978000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-988181000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	599797000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2632235000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1251456000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1644054000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1851253000	USD
CY2021Q1	phm	Interestpaidcapitalizednet Interestpaidcapitalizednet	17368000	USD
CY2020Q1	phm	Interestpaidcapitalizednet Interestpaidcapitalizednet	14019000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	15574000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5540000	USD
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</span></div>
CY2021Q1	phm	Write Off Of Deposits And Pre Acquisition Costs WriteOffOfDepositsAndPreAcquisitionCosts	1368000	USD
CY2020Q1	phm	Write Off Of Deposits And Pre Acquisition Costs WriteOffOfDepositsAndPreAcquisitionCosts	4332000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4992000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4557000	USD
CY2021Q1	us-gaap	Interest Income Other InterestIncomeOther	631000	USD
CY2020Q1	us-gaap	Interest Income Other InterestIncomeOther	3807000	USD
CY2021Q1	us-gaap	Interest Expense Other InterestExpenseOther	135000	USD
CY2020Q1	us-gaap	Interest Expense Other InterestExpenseOther	797000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	827000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	567000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2398000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2788000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2639000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2524000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	589600000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	449500000	USD
CY2021Q1	phm	Contractassetinsurancerenewals Contractassetinsurancerenewals	39400000	USD
CY2020Q4	phm	Contractassetinsurancerenewals Contractassetinsurancerenewals	38500000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	304107000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	203711000	USD
CY2021Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	298000	USD
CY2020Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	273000	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	2154000	USD
CY2020Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	1537000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	301655000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	201901000	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	2154000	USD
CY2020Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	1537000	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	2149000	USD
CY2020Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	1530000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	301660000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	201908000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	265407000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	270000000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	605000	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1218000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	266012000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	271218000	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.14
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.74
CY2021Q1	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	495000000.0	USD
CY2020Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	565000000.0	USD
CY2021Q1	us-gaap	Inventory Real Estate Mortgage Loans Held In Inventory InventoryRealEstateMortgageLoansHeldInInventory	481500000	USD
CY2020Q4	us-gaap	Inventory Real Estate Mortgage Loans Held In Inventory InventoryRealEstateMortgageLoansHeldInInventory	539100000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	77400000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	30900000	USD
CY2021Q1	us-gaap	Maximum Length Of Time Hedged In Cash Flow Hedge1 MaximumLengthOfTimeHedgedInCashFlowHedge1	P60D
CY2021Q1	us-gaap	Derivative Instruments In Hedges Assets At Fair Value DerivativeInstrumentsInHedgesAssetsAtFairValue	32884000	USD
CY2021Q1	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue	553000	USD
CY2020Q4	us-gaap	Derivative Instruments In Hedges Assets At Fair Value DerivativeInstrumentsInHedgesAssetsAtFairValue	16848000	USD
CY2020Q4	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue	6621000	USD
CY2021Q1	phm	Assets In Scope Under Accounting Standards Codification326 AssetsInScopeUnderAccountingStandardsCodification326	186400000	USD
CY2020Q4	phm	Assets In Scope Under Accounting Standards Codification326 AssetsInScopeUnderAccountingStandardsCodification326	176200000	USD
CY2021Q1	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	3594406000	USD
CY2020Q4	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	3086740000	USD
CY2021Q1	us-gaap	Land Available For Development LandAvailableForDevelopment	3913349000	USD
CY2020Q4	us-gaap	Land Available For Development LandAvailableForDevelopment	4137318000	USD
CY2021Q1	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	467456000	USD
CY2020Q4	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	497740000	USD
CY2021Q1	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	7975211000	USD
CY2020Q4	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	7721798000	USD
CY2020Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	193409000	USD
CY2019Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	210383000	USD
CY2021Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	34627000	USD
CY2020Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	39913000	USD
CY2021Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	34684000	USD
CY2020Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	36871000	USD
CY2021Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	193352000	USD
CY2020Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	213425000	USD
CY2021Q1	us-gaap	Purchase Options Land PurchaseOptionsLand	319820000	USD
CY2021Q1	phm	Remaining Purchase Price Of All Land Option Agreements RemainingPurchasePriceOfAllLandOptionAgreements	4304720000	USD
CY2020Q4	us-gaap	Purchase Options Land PurchaseOptionsLand	291864000	USD
CY2020Q4	phm	Remaining Purchase Price Of All Land Option Agreements RemainingPurchasePriceOfAllLandOptionAgreements	3773568000	USD
CY2021Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
CY2020Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	5386000	USD
CY2021Q1	phm	Net Realizable Value Adjustments Land Held For Sale Total NetRealizableValueAdjustmentsLandHeldForSaleTotal	0	USD
CY2020Q1	phm	Net Realizable Value Adjustments Land Held For Sale Total NetRealizableValueAdjustmentsLandHeldForSaleTotal	11000	USD
CY2021Q1	phm	Write Off Of Deposits And Pre Acquisition Costs WriteOffOfDepositsAndPreAcquisitionCosts	1368000	USD
CY2020Q1	phm	Write Off Of Deposits And Pre Acquisition Costs WriteOffOfDepositsAndPreAcquisitionCosts	4332000	USD
CY2021Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	1368000	USD
CY2020Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	9729000	USD
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6	segment
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	394052000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	263769000	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-61500000	USD
CY2021Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	1368000	USD
CY2020Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	9729000	USD
CY2021Q1	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	3594406000	USD
CY2021Q1	us-gaap	Land Available For Development LandAvailableForDevelopment	3913349000	USD
CY2021Q1	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	467456000	USD
CY2021Q1	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	7975211000	USD
CY2021Q1	us-gaap	Assets Assets	11445741000	USD
CY2020Q4	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	3086740000	USD
CY2020Q4	us-gaap	Land Available For Development LandAvailableForDevelopment	4137318000	USD
CY2020Q4	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	497740000	USD
CY2020Q4	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	7721798000	USD
CY2020Q4	us-gaap	Assets Assets	12205498000	USD
CY2021Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	12222000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	13750000	USD
CY2021Q1	us-gaap	Senior Notes SeniorNotes	1987778000	USD
CY2020Q4	us-gaap	Senior Notes SeniorNotes	2712204000	USD
CY2021Q1	us-gaap	Other Notes Payable OtherNotesPayable	44159000	USD
CY2020Q4	us-gaap	Other Notes Payable OtherNotesPayable	40098000	USD
CY2021Q1	us-gaap	Notes Payable NotesPayable	2031937000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	2752302000	USD
CY2021Q1	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	2507209000	USD
CY2020Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	3415662000	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-61500000	USD
CY2021Q1	us-gaap	Other Notes Payable OtherNotesPayable	44200000	USD
CY2020Q4	us-gaap	Other Notes Payable OtherNotesPayable	40100000	USD
CY2021Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P3Y
CY2021Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	1000000000.0	USD
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1500000000	USD
CY2021Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	700000000.0	USD
CY2021Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	235700000	USD
CY2020Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	249700000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	764300000	USD
CY2020Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	750300000	USD
CY2021Q1	us-gaap	Dividends Dividends	37300000	USD
CY2020Q1	us-gaap	Dividends Dividends	32600000	USD
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.228
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.228
CY2021Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	21300000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	32700000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	33500000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	30900000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	3200000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2800000	USD
CY2021Q1	us-gaap	Other Notes Payable OtherNotesPayable	44159000	USD
CY2020Q4	us-gaap	Other Notes Payable OtherNotesPayable	40098000	USD
CY2021Q1	us-gaap	Senior Notes SeniorNotes	2000000000.0	USD
CY2020Q4	us-gaap	Senior Notes SeniorNotes	2700000000	USD
CY2021Q1	phm	Maximum Product Warranty In Years MaximumProductWarrantyInYears	P10Y
CY2021Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	235700000	USD
CY2021Q1	phm	Surety Bonds Outstanding SuretyBondsOutstanding	1600000000	USD
CY2020Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	249700000	USD
CY2020Q4	phm	Surety Bonds Outstanding SuretyBondsOutstanding	1500000000	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	82744000	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	91389000	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	17344000	USD
CY2020Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	15039000	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	15493000	USD
CY2020Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	18276000	USD
CY2021Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-788000	USD
CY2020Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	243000	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	83807000	USD
CY2020Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	88395000	USD
CY2021Q1	phm	Number Of Claims Under Review By Management NumberOfClaimsUnderReviewByManagement	1000	claim
CY2021Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	653100000	USD
CY2020Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	641800000	USD
CY2021Q1	phm	Incurred But Not Reported Percentage Of Liability Reserves IncurredButNotReportedPercentageOfLiabilityReserves	0.67
CY2020Q4	phm	Incurred But Not Reported Percentage Of Liability Reserves IncurredButNotReportedPercentageOfLiabilityReserves	0.68
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	91400000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1100000	USD
CY2020Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	641779000	USD
CY2019Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	709798000	USD
CY2021Q1	phm	Additions To Self Insurance Reserves AdditionsToSelfInsuranceReserves	19542000	USD
CY2020Q1	phm	Additions To Self Insurance Reserves AdditionsToSelfInsuranceReserves	18449000	USD
CY2021Q1	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	-6082000	USD
CY2020Q1	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	1300000	USD
CY2021Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	2171000	USD
CY2020Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	10375000	USD
CY2021Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	653068000	USD
CY2020Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	719172000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	69000000.0	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	88300000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	71300000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	102655000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9600000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	5300000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	5900000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	10200000	USD
CY2020Q1	us-gaap	Lease Cost LeaseCost	9900000	USD
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	1900000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	1900000	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2900000	USD
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2200000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	15969000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22646000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	20567000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	14374000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9521000	USD
CY2021Q1	phm	Lessee Operating Lease Liabilitytobe Paidafter Year Four LesseeOperatingLeaseLiabilitytobePaidafterYearFour	19578000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	14324000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	88331000	USD
CY2021Q1	phm	Lessee Operating Lease Lease Not Yet Commenced Liability LesseeOperatingLeaseLeaseNotYetCommencedLiability	1700000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M24D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.056

Files In Submission

Name	View Source	Status
0000822416-21-000018-index-headers.html	Edgar Link	pending
0000822416-21-000018-index.html	Edgar Link	pending
0000822416-21-000018.txt	Edgar Link	pending
0000822416-21-000018-xbrl.zip	Edgar Link	pending
exhibit31aceocertification.htm	Edgar Link	pending
exhibit31bcfocertification.htm	Edgar Link	pending
exhibit32-certification331.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
phm-20210331.htm	Edgar Link	pending
phm-20210331.xsd	Edgar Link	pending
phm-20210331_cal.xml	Edgar Link	unprocessable
phm-20210331_def.xml	Edgar Link	unprocessable
phm-20210331_htm.xml	Edgar Link	completed
phm-20210331_lab.xml	Edgar Link	unprocessable
phm-20210331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PHM
PULTEGROUP INC/MI/ Stock $phm

2021 Q1 Form 10-Q Financial Statement

#000082241621000018 Filed on April 27, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHM PULTEGROUP INC/MI/ Stock $phm

2021 Q1 Form 10-Q Financial Statement

#000082241621000018 Filed on April 27, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHM
PULTEGROUP INC/MI/ Stock $phm